We are live on ! Find out more
Temasek Holdings

Temasek Holdings Portfolio holdings

AUM $30.5B
1-Year Est. Return 13.98%
This Fund
S&P 500
This Quarter Est. Return
-0.17%
1 Year Est. Return
+13.98%
3 Year Est. Return
+73.05%
5 Year Est. Return
+59.18%
10 Year Est. Return
+409.11%
AUM
$16.3B
AUM Growth
-$906M
Cap. Flow
-$922M
Cap. Flow %
-5.67%
Top 10 Hldgs %
71.33%
Holding
67
New
6
Increased
8
Reduced
6
Closed
4

Sector Composition

1 Consumer Discretionary 43.88%
2 Communication Services 14.5%
3 Healthcare 13.23%
4 Financials 8.64%
5 Materials 8.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MA icon
26
Mastercard
MA
$479B
$140M 0.86%
923,068
ONC
27
BeOne Medicines Ltd
ONC
$32.3B
$125M 0.77%
1,280,000
+900,000
+237% +$82.4M
WP
28
DELISTED
Worldpay, Inc.
WP
$97.6M 0.6%
1,327,057
+345,000
+35% +$24.7M
AVGO icon
29
Broadcom
AVGO
$1.77T
$96.6M 0.59%
3,760,500
VNET
30
VNET Group
VNET
$2.11B
$86M 0.53%
10,778,004
CBPO
31
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$78M 0.48%
990,000
+953,005
+2,576% +$79.2M
REGN icon
32
Regeneron Pharmaceuticals
REGN
$70.6B
$71.7M 0.44%
190,621
DNLI icon
33
Denali Therapeutics
DNLI
$3.75B
$69M 0.42%
+4,410,457
New +$79.3M
TOUR
34
Tuniu
TOUR
$55.4M
$62.9M 0.39%
819,444
ILMN icon
35
Illumina
ILMN
$28.1B
$60.6M 0.37%
285,024
CHRS icon
36
Coherus Oncology
CHRS
$214M
$57.7M 0.35%
6,556,116
MON
37
DELISTED
Monsanto Co
MON
$50.1M 0.31%
429,184
KREF
38
KKR Real Estate Finance Trust
KREF
$469M
$48.8M 0.3%
2,439,024
JUNO
39
DELISTED
Juno Therapeutics, Inc.
JUNO
$41.9M 0.26%
915,750
BIIB icon
40
Biogen
BIIB
$30.2B
$37.8M 0.23%
118,644
VRTX icon
41
Vertex Pharmaceuticals
VRTX
$123B
$36.7M 0.23%
244,582
AMGN icon
42
Amgen
AMGN
$196B
$32.8M 0.2%
188,527
IBN icon
43
ICICI Bank
IBN
$106B
$27.3M 0.17%
2,808,987
CELG
44
DELISTED
Celgene Corp
CELG
$26.7M 0.16%
255,406
EMWP
45
DELISTED
Eros Media World PLC
EMWP
$26.6M 0.16%
137,766
INCY icon
46
Incyte
INCY
$23.4B
$23.9M 0.15%
252,160
KRE icon
47
State Street SPDR S&P Regional Banking ETF
KRE
$4.95B
$20.2M 0.12%
343,800
-171,900
-33% -$9.88M
JPM icon
48
JPMorgan Chase
JPM
$910B
$18.8M 0.12%
176,225
-88,112
-33% -$8.92M
ACIU icon
49
AC Immune
ACIU
$219M
$17.1M 0.11%
1,337,500
NETS
50
DELISTED
Netshoes (Cayman) Limited
NETS
$16.4M 0.1%
2,071,127

Similar funds

Temasek Holdings's Q4 2017 Portfolio in Review

As of Q4 2017, Temasek Holdings held 67 positions worth $16.3B, down 5.3% from $17.2B the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Temasek Holdings withdrew a net $922M in Q4 2017, closing 4 positions and reducing 6 holdings. Its most notable exit was Level 3 Communications Inc, an estimated $3.47B position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 44% of assets, up from 42% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Temasek Holdings opened a new position in Lumen worth $1.55B.

  • Temasek Holdings's largest Q4 2017 buy was Lumen: 92,904,239 shares worth $1.55B.
  • Temasek Holdings added most to BeOne Medicines Ltd in Q4 2017, an estimated $82.4M increase.
  • Temasek Holdings's biggest Q4 2017 reduction was State Street SPDR S&P Regional Banking ETF, cutting an estimated $9.88M.
  • Temasek Holdings fully exited Level 3 Communications Inc in Q4 2017, selling an estimated $3.47B.
  • Temasek Holdings's ten largest holdings make up 71% of its $16.3B portfolio in Q4 2017.
  • Temasek Holdings opened 6 new positions and closed 4 in Q4 2017.
  • Temasek Holdings's portfolio value fell 5.3% quarter-over-quarter to $16.3B.

Based on Temasek Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.